Drug Pipeline

Belvarafenib Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07449754 Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or… Advanced or Metastatic Melanoma Recruiting
NCT04589845 Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… Solid Tumors Active, Not Recruiting
Phase 1
NCT04835805 A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in… Melanoma Active, Not Recruiting
Sponsors Running Belvarafenib Trials
Hoffmann-La Roche (1) Genentech, Inc. (1) Hanmi Pharmaceutical Company Limited (1)
Disease Areas
Melanoma (2)
Get alerts when Belvarafenib trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free